John Nagle is an experienced litigator and counselor who has represented businesses and individuals in the efficient resolution of all manner of disputes. He represents plaintiffs and defendants in general business litigation and has worked with clients ranging from homeowners to small businesses to Fortune 500 companies. He handles all aspects of litigation, including negotiations, alternative dispute resolution, discovery, depositions, trial, and appeal.
John has helped clients with numerous complex issues and has significant experience with breach of contract claims, enforcement of restrictive covenants, protection of trade secrets, class action defense, construction disputes, antitrust, and consumer protection. He has worked extensively on government investigations and compliance with federal statutes and regulations in highly regulated industries, including health care and life sciences.
Before Bowditch
John practiced at larger law firms in Boston where he represented multinational companies in complex class action litigation and defense of government enforcement actions. He has served as first chair at trial in federal court and had significant trial experience in state court as well as interactions with the U.S. Department of Justice and multiple State Attorney General offices.
Affiliations
- Committee Chairman, Boston, Georgetown Alumni Admissions Program (2007-present)
- Board of Advisors, Georgetown Alumni Admissions Program (2013-present)
Bar Admissions
- Massachusetts
- United States District Court for the District of Massachusetts
- United States Court of Appeals for the First Circuit
Education
- J.D., Georgetown University Law Center
- B.A., cum laude, Georgetown University
- Trinity College, Dublin, Ireland
- Obtained a settlement in excess of $1 million on behalf of a contractor against a national builder/developer that refused payment for completed services. The resolution followed the strategic invocation of Massachusetts’ Prompt Pay Act, after which the opposing party capitulated and wired payment to the client.
- Negotiated a substantial settlement on behalf of developer/owner of rehabilitated apartment building against architectural firm and designer of non-functional plumbing system that had caused delay to occupancy.
- Procured settlements in excess of $500,000 for home renovation contractor in disputes with homeowners regarding payment of final invoices.
- Secured dismissal of claims for breach of contract for lab space tenant who needed to break a lease due to change in economic conditions.
- Assisted battery technology company with termination of multiple leases and winddown of operations due to change in government policy.
- Represented business owner before the Federal Trade Commission in response to allegations of fake online reviews and succeeded in persuading FTC not to pursue claims.
- Assisted veterinarian in separation from employer and starting new independent practice without violating restrictive covenants.
- Represented the owner/developer of a senior living center in prosecuting breach-of-contract and professional malpractice claims against an architect for failure to comply with accessibility requirements.
- Obtained multi-million dollar settlement for global public relations firm in dispute with former executives over violation of restrictive covenants.
- Successfully represented founder of life sciences data company in dispute with former investor alleging fraud and breach of contract related to sale of stock, resulting in dismissal with prejudice for all claims against client, affirmed on appeal.
- Defense of multinational pharmaceutical company in nationwide multidistrict antitrust class action brought by various purchasers alleging an industry-wide cartel involving price-fixing and customer allocation agreements and conspiracies, and in related direct action litigation.
- Counseled and conducted investigations for multinational pharmaceutical company in response to grand jury and investigatory subpoenas from the Department of Justice and state attorneys general concerning price fixing and market allocation for generic drugs.
- Advised global drug manufacturer in responding to civil investigative demand related to calculation and reporting of prices used for Medicaid and Medicare rebates.
- Representation of drug distributor in nationwide litigation relating to the distribution of prescription opioid medications in connection with opioid abuse crisis.
- Served as counsel to drug manufacturer on antitrust risks associated with potential inaccurate listing of patent information in FDA Orange Book.
- Successfully represented founder of life sciences data company in dispute with former investor alleging fraud and breach of contract related to sale of stock, resulting in dismissal with prejudice for all claims against client, affirmed on appeal.
- Recovered investment capital for medical technology investors resulting in recoupment of entire investment.
- Defended NYSE-listed drug manufacturers regarding claims throughout the U.S. challenging drug pricing practices, violations of state and federal False Claims acts, Federal Anti-Kickback statute, state consumer protection acts, and other state statutes governing business practices.